DA, W., AM, D., V, A., DC, M., B, S., LM, H., . . . AM, G. (2018). Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy. Pediatric blood & cancer, 65(5), e26960. https://doi.org/10.1002/pbc.26960
Chicago Style (17th ed.) CitationDA, Witt, et al. "Specific Expression of PD-L1 in RELA-fusion Supratentorial Ependymoma: Implications for PD-1-targeted Therapy." Pediatric Blood & Cancer 65, no. 5 (2018): e26960. https://doi.org/10.1002/pbc.26960.
MLA (9th ed.) CitationDA, Witt, et al. "Specific Expression of PD-L1 in RELA-fusion Supratentorial Ependymoma: Implications for PD-1-targeted Therapy." Pediatric Blood & Cancer, vol. 65, no. 5, 2018, p. e26960, https://doi.org/10.1002/pbc.26960.